欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Proteases/Proteasome > Marimastat

浏览历史

S80401

Marimastat

源叶(MedMol) 95%
  • 英文名:
  • Marimastat
  • 别名:
  • 马立马司他;(2R,3s)-n1-((s)-3,3-二甲基-1-(甲基氨基)-1-氧代-2-丁基)-n4,3-二羟基-2-异丁基磺酰胺;Marimastat; BB-2516;
  • CAS号:
  • 154039-60-8
  • 分子式:
  • C15H29N3O5
  • 分子量:
  • 331.408
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S80401-5mg 95% ¥500.00元 5 - - - EA 加入购物车
源叶(MedMol) S80401-10mg 95% ¥690.00元 6 - - - EA 加入购物车
源叶(MedMol) S80401-25mg 95% ¥990.00元 6 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Marimastat (BB2516) is a broad spectrum and orally bioavailable inhibitor of MMPs, with potent activity against MMP-9 (IC50=3 nM), MMP-1 (IC50=5 nM), MMP-2 (IC50=6 nM), MMP-14 (IC50=9 nM) and MMP-7 (IC50=13 nM), used in the treatment of cancer. Marimastat (BB2516) is an angiogenesis and metastasis inhibitor, which limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes
  • 靶点: MMP-3:3 nM (IC50);MMP-1:5 nM (IC50);MMP-2:6 nM (IC50);MMP-14:9 nM (IC50);MMP-7:13 nM (IC50);MMP
  • 体内研究:
    Animals receiving chemoradiation + Marimastat (BB2516) (8.7 mg/kg) have statistically significant delayed growth, compared to animals receiving chemoradiation alone. Marimastat (BB2516) may work in combination with chemotherapy and radiation to inhibit tumor growth
  • 参考文献:
    1. Rasmussen HS, et al. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther. 1997;75(1):69-75. 2. Yu M, et al. Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing Cytotoxicity. ChemistryOpen. 2013 Jun;2(3):99-105. 3. van Wijngaarden J, et al. An in vitro model that can distinguish between effects on angiogenesis and on established vasculature: actions of TNP-470, marimastat and the tubulin-binding agent Ang-510. Biochem Biophys Res Commun. 2010 Jan 8;391(2):1161-5. 4. Skipper JB, et al. In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec. 2009;71(1):1-5.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 3.017 ml 15.087 ml 30.174 ml
    5 mM 0.603 ml 3.017 ml 6.035 ml
    10 mM 0.302 ml 1.509 ml 3.017 ml
    50 mM 0.06 ml 0.302 ml 0.603 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。